Physician profile
Michael B Huck
NPI 1043577729
$418.95
in general payments reported to CMS, 2019-2025
11 companies · $69.63 in 2025
The $69.63 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.93 · 2020: $40.25 · 2021: $52.79 · 2023: $132 · 2024: $98.12 · 2025: $69.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $165.40 | 2021-2023 | Da Vinci Surgical System |
| Kerecis Limited | $45.26 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Csl Behring | $40.58 | 2020-2023 | Kcentra |
| Hologic Sales and Service, LLC | $29.88 | 2025 | Magseed, Magtrace |
| Janssen Biotech, INC. | $28.69 | 2025 | Erleada |
| Integra Lifesciences Corporation | $26.98 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medtronic, INC. | $19.74 | 2024 | Progrip |
| Axonics, INC. | $19.29 | 2020 | |
| Merck Sharp & Dohme LLC | $17.20 | 2024 | Keytruda |
| Covidien LP | $13.07 | 2019 | |
| Shire North American Group INC | $12.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Huck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.